Avoiding The Risk Of A Non-Transparent Clinical Supply Solution

One of the top challenges and a major cause of delays in sourcing comparators and co-therapies, as reported by participants in the Tufts Center for the Study of Drug Development¹², is associated with obtaining required documentation – which includes equivalency documentation, certificates of conformity, certificates of analysis, and Bovine Spongiform Encephalopathy/Transmitting Animal Spongiform Encephalopathy (BSE/TSE) statements – from the manufacturer, along with temperature excursion and stability data.